Reassessing the Upper Limit of Normal in High Sensitivity Cardiac Troponin I Assays
Greater scrutiny is needed in evaluating high sensitivity cardiac troponin I levels for the purpose of excluding or diagnosing acute myocardial infarction.
All articles by Brandon May
Riociguat Therapy Linked to Improved Clinical Parameters in Inoperable CTEPH
Riociguat has been shown to reduce clinical worsening in patients with technical inoperable and residual chronic thromboembolic pulmonary hypertension.
Supraflex Noninferior to Xience for Reducing Device-Related Complications After PCI
The sirolimus-eluting Supraflex coronary stent with absorbable polymer coating was noninferior to a currently best-in-class drug-eluting stent at 12 months.
No Difference Between Antiplatelet Agents vs Anticoagulants in Recurrent Stroke Risk After Cervical Dissection
Researchers found a low rate of recurrent stroke after carotid and vertebral dissection and no difference between antiplatelet agents and anticoagulants.
Do CAD Outcomes Differ Between Those Enrolled in Medicare Advantage vs Fee-for-Service Medicare?
Researchers found that patients with coronary artery disease enrolled in Medicare Advantage had a slightly higher comorbidity burden and received higher quality care than their traditional fee-for-service Medicare counterparts.
Genetic Variations in Homozygous vs Heterogeneous Familial Hypercholesterolemia
Researchers analyzed the genetic differences between homo- and heterozygous familial hypercholesterolemia in a pediatric population.
High Discordance Between LDL-C, Lp(a) Reduction in Response to Evolucumab
There is a high prevalence of discordance in the reduction of low-density lipoprotein cholesterol (LDL-C) and lipoprotein(a) (Lp[a]) in response to evolocumab treatment.
Dapagliflozin Reduces MACE, CV Death in Patients With T2D and Prior MI
Dapagliflozin reduces MACE, CV death, and risk for heart failure hospitalization in patients with type 2 diabetes and prior MI.
New ACC/AHA Guideline for Primary Prevention of CVD Presented at ACC 2019
The American College of Cardiology and American Heart Association have released a new evidence-based guideline detailing the primary prevention of cardiovascular disease.
Statin Pretreatment Associated With Reduced Infarct Volume in Ischemic Stroke
Statin pretreatment is associated with reduced infarct volumes, especially in acute ischemic stroke resulting from large artery atherosclerosis.
Next post in Metabolic
